About Ramachandran Murali
Ramachandran Murali is VP of Research and Development at Kairos Pharma.
Ramachandran Murali reports to the SEC as an officer of 1 public company.
Ramachandran Murali first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Ramachandran Murali in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ramachandran Murali works with at each company, as listed on that company's latest Form D.
Kairos Pharma, LTD. · Form D, Jan 28, 2025
HB
Hyun Bae
Independent Director
NB
Neil Bhowmick
Chief Scientific Officer
JY
John Yu
Chairman, Chief Executive Officer, and Director
HK
Hansoo Michael Keyoung
Independent Director
DS
Doug Samuelson
Chief Financial Officer
RS
Rahul Singhvi
Independent Director